Gainers
- Avenue Therapeutics ATXI shares rose 102.3% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $14.3 million.
- CTI BioPharma CTIC stock rose 60.0% to $3.04. The market value of their outstanding shares is at $293.9 million.
- GBS GBS stock moved upwards by 55.89% to $0.72. The market value of their outstanding shares is at $10.6 million.
- Chembio Diagnostics CEMI stock rose 14.52% to $1.1. The company's market cap stands at $33.0 million.
- DarioHealth DRIO stock moved upwards by 12.32% to $8.2. The market value of their outstanding shares is at $135.9 million.
- Atea Pharmaceuticals AVIR stock rose 11.19% to $7.05. The market value of their outstanding shares is at $585.8 million. As per the press release, Q4 earnings came out yesterday.
Losers
- GoodRx Holdings GDRX shares decreased by 33.9% to $18.12 during Tuesday's pre-market session. The company's market cap stands at $7.2 billion. As per the press release, Q4 earnings came out yesterday.
- Semler Scientific SMLR shares fell 21.92% to $57.0. The market value of their outstanding shares is at $385.1 million. As per the news, the Q4 earnings report came out yesterday.
- RadNet RDNT stock fell 14.88% to $21.0. The company's market cap stands at $1.1 billion. As per the press release, Q4 earnings came out today.
- Heron Therapeutics HRTX stock declined by 14.65% to $6.06. The market value of their outstanding shares is at $617.7 million. As per the news, the Q4 earnings report came out yesterday.
- Cidara Therapeutics CDTX stock decreased by 13.02% to $0.61. The company's market cap stands at $40.6 million.
- China SXT Pharmaceuticals SXTC stock decreased by 12.44% to $0.19. The company's market cap stands at $5.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in